Hayden Royal’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$311K Buy
3,017
+16
+0.5% +$1.48K 0.73% 45
2021
Q3
$255K Sell
3,001
-4,013
-57% -$336K 0.42% 65
2021
Q2
$585K Sell
7,014
-134
-2% -$11K 0.32% 78
2021
Q1
$538K Buy
7,148
+973
+16% +$70.9K 0.31% 78
2020
Q4
$422K Buy
6,175
+973
+19% +$63.3K 0.23% 101
2020
Q3
$303K Buy
5,202
+387
+8% +$24.1K 0.16% 144
2020
Q2
$313K Sell
4,815
-4,065
-46% -$256K 0.18% 104
2020
Q1
$527K Buy
8,880
+833
+10% +$55.6K 0.31% 88
2019
Q4
$579K Buy
8,047
+3,285
+69% +$231K 0.29% 88
2019
Q3
$300K Buy
4,762
+98
+2% +$5.81K 0.26% 126
2019
Q2
$270K Buy
+4,664
New +$251K 0.29% 111

Other funds holding CVS

Hayden Royal's CVS Position: Q4 2021 in Review

Hayden Royal increased its CVS Health (CVS) stake by 0.53% in Q4 2021, buying an estimated $1.48K and bringing the position to 3,017 shares worth $311K. The position accounts for 0.73% of the portfolio, ranked #45.

Hayden Royal first reported a position in CVS in Q2 2019 and has held it in 11 quarters since. The position peaked at $585K in Q2 2021. 2,342 funds tracked by Wall St. Rank hold CVS as of Q4 2021.

  • Hayden Royal held 3,017 shares of CVS Health worth $311K as of Q4 2021.
  • Hayden Royal bought 16 CVS Health shares in Q4 2021, an estimated $1.48K.
  • CVS Health made up 0.73% of Hayden Royal's portfolio in Q4 2021, its #45 holding.
  • Hayden Royal first reported a position in CVS Health in Q2 2019 and has held it in 11 quarters since.
  • Hayden Royal's CVS Health position peaked at $585K in Q2 2021.
  • 2,342 funds tracked by Wall St. Rank held CVS Health as of Q4 2021.

Based on Hayden Royal's 13F filing for Q4 2021, filed 7 Feb 2022.